Abstract
Takayasu arteritis (TA) and Crohn's disease (CD) are chronic inflammatory diseases with granulomatous nature. Here, we report a case of TA with a silent course of CD who was refractory to corticosteroid and immunosuppressive treatments and improved with adalimumab therapy.
MeSH terms
-
Adalimumab
-
Adrenal Cortex Hormones / therapeutic use*
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Colonoscopy
-
Comorbidity
-
Crohn Disease / diagnosis
-
Crohn Disease / drug therapy*
-
Crohn Disease / epidemiology*
-
Female
-
Humans
-
Immunosuppressive Agents / therapeutic use*
-
Takayasu Arteritis / diagnosis
-
Takayasu Arteritis / drug therapy*
-
Takayasu Arteritis / epidemiology*
-
Treatment Failure
-
Treatment Outcome
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors
-
Young Adult
Substances
-
Adrenal Cortex Hormones
-
Antibodies, Monoclonal, Humanized
-
Immunosuppressive Agents
-
Tumor Necrosis Factor-alpha
-
Adalimumab